Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FARAIDOON D GOLYAN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1174559926
CMS profile
234861
Location
FOREST HILLS, NY

General Payments · PY2018–2024

$5,798.92

  • Reported across 193 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$664.51

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $664.51 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,304.71 47
PY2019 $2,143.29 37
PY2020 $119.49 5
PY2021 $142.07 8
PY2022 $815.26 43
PY2023 $609.59 19
PY2024 $664.51 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $14.59 10/09/2024 Food and Beverage Undisputed 01/23/2026 1124882146 CMS
Alnylam Pharmaceuticals Inc. $22.64 04/02/2024 Food and Beverage Undisputed 01/23/2026 1125824678 CMS
Alnylam Pharmaceuticals Inc. $29.22 12/16/2024 Food and Beverage Undisputed 01/23/2026 1125824793 CMS
Amgen Inc. $22.07 01/31/2024 Food and Beverage Undisputed 01/23/2026 1111586066 CMS
AstraZeneca Pharmaceuticals LP $14.46 01/23/2024 Food and Beverage Undisputed 01/23/2026 1104441837 CMS
AstraZeneca Pharmaceuticals LP $18.79 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104470488 CMS
AstraZeneca Pharmaceuticals LP $21.23 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104261017 CMS
AstraZeneca Pharmaceuticals LP $19.02 10/17/2024 Food and Beverage Undisputed 01/23/2026 1105519923 CMS
Boston Scientific Corporation $22.48 08/06/2024 Food and Beverage Undisputed 01/23/2026 1092286297 CMS
E.R. Squibb & Sons, L.L.C. $18.33 03/21/2024 Food and Beverage Undisputed 01/23/2026 1101356002 CMS
E.R. Squibb & Sons, L.L.C. $19.45 09/16/2024 Food and Beverage Undisputed 01/23/2026 1101356042 CMS
Inspire Medical Systems, Inc. $28.04 04/11/2024 Food and Beverage Undisputed 01/23/2026 1148057073 CMS
Janssen Pharmaceuticals, Inc $33.27 04/16/2024 Food and Beverage Undisputed 01/23/2026 1078108810 CMS
Janssen Pharmaceuticals, Inc $26.95 07/22/2024 Food and Beverage Undisputed 01/23/2026 1078108812 CMS
Merck Sharp & Dohme LLC $33.46 03/28/2024 Food and Beverage Undisputed 01/23/2026 1141806727 CMS
Merck Sharp & Dohme LLC $24.26 05/30/2024 Food and Beverage Undisputed 01/23/2026 1141806725 CMS
Merck Sharp & Dohme LLC $32.87 07/11/2024 Food and Beverage Undisputed 01/23/2026 1141902150 CMS
Merck Sharp & Dohme LLC $26.38 08/27/2024 Food and Beverage Undisputed 01/23/2026 1141947897 CMS
Novartis Pharmaceuticals Corporation $8.25 01/10/2024 Food and Beverage Undisputed 01/23/2026 1086866613 CMS
Novartis Pharmaceuticals Corporation $17.09 02/07/2024 Food and Beverage Undisputed 01/23/2026 1086866605 CMS
Novartis Pharmaceuticals Corporation $14.98 04/10/2024 Food and Beverage Undisputed 01/23/2026 1086866621 CMS
Novartis Pharmaceuticals Corporation $4.39 05/29/2024 Food and Beverage Undisputed 01/23/2026 1086866633 CMS
Novartis Pharmaceuticals Corporation $18.83 06/12/2024 Food and Beverage Undisputed 01/23/2026 1086866635 CMS
Novartis Pharmaceuticals Corporation $3.09 07/24/2024 Food and Beverage Undisputed 01/23/2026 1086866647 CMS
Novartis Pharmaceuticals Corporation $24.39 08/28/2024 Food and Beverage Undisputed 01/23/2026 1086866649 CMS
Novartis Pharmaceuticals Corporation $29.24 09/11/2024 Food and Beverage Undisputed 01/23/2026 1086866651 CMS
Novartis Pharmaceuticals Corporation $6.29 10/02/2024 Food and Beverage Undisputed 01/23/2026 1086866665 CMS
Novartis Pharmaceuticals Corporation $13.95 10/23/2024 Food and Beverage Undisputed 01/23/2026 1086866675 CMS
Novartis Pharmaceuticals Corporation $3.36 10/30/2024 Food and Beverage Undisputed 01/23/2026 1086866677 CMS
Novartis Pharmaceuticals Corporation $6.98 10/30/2024 Food and Beverage Undisputed 01/23/2026 1086866679 CMS
Novartis Pharmaceuticals Corporation $7.05 11/13/2024 Food and Beverage Undisputed 01/23/2026 1086866681 CMS
Novartis Pharmaceuticals Corporation $16.19 12/04/2024 Food and Beverage Undisputed 01/23/2026 1086866687 CMS
SCPHARMACEUTICALS INC. $30.79 10/09/2024 Food and Beverage Undisputed 01/23/2026 1132302772 CMS
SCPHARMACEUTICALS INC. $32.13 12/18/2024 Food and Beverage Undisputed 01/23/2026 1132321532 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.